Published in J Immunol on July 01, 1996
Understanding the benign nature of SIV infection in natural hosts. J Clin Invest (2007) 2.43
Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest (1999) 1.91
Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China. Clin Infect Dis (2008) 1.72
Vgamma2Vdelta2+ T cells and anti-microbial immune responses. Microbes Infect (2003) 1.18
Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys. J Virol (2003) 1.16
Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections. Mol Med (1997) 1.16
Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections. J Virol (2007) 1.07
Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells. AIDS (2009) 1.05
Development of Vgamma2Vdelta2+ T cell responses during active mycobacterial coinfection of simian immunodeficiency virus-infected macaques requires control of viral infection and immune competence of CD4+ T cells. J Infect Dis (2004) 1.03
Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model. PLoS One (2011) 1.02
Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection. PLoS Pathog (2015) 1.02
gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. Immunology (2000) 1.02
Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). Clin Immunol (2008) 1.01
Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits. J Immunol (2009) 0.99
Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood (2010) 0.99
Inhibition of phosphoantigen-mediated gammadelta T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells. Immunology (2008) 0.98
Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J Virol (2003) 0.98
HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS. Blood (2011) 0.96
Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin Immunopathol (2009) 0.96
Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications. Cell Mol Immunol (2012) 0.96
Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS. J Leukoc Biol (2008) 0.96
Response of gammadelta T Cells to plant-derived tannins. Crit Rev Immunol (2008) 0.96
The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin Exp Immunol (2000) 0.92
Vdelta2+ gammadelta T cell function in Mycobacterium tuberculosis- and HIV-1-positive patients in the United States and Uganda: application of a whole-blood assay. J Infect Dis (2005) 0.91
V gamma 9V delta 2 T-cell anergy and complementarity-determining region 3-specific depletion during paroxysm of nonendemic malaria infection. Infect Immun (2003) 0.86
γδ T Cells in HIV Disease: Past, Present, and Future. Front Immunol (2015) 0.86
Predominance of Vgamma9/Vdelta2 T lymphocytes in the cerebrospinal fluid of children with tuberculous meningitis: reversal after chemotherapy. Mol Med (1999) 0.85
gammadelta T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection. Thorax (2002) 0.83
Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques. Curr HIV Res (2008) 0.79
Characterization of γδT cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol (2014) 0.79
Human gamma delta T regulatory cells in cancer: fact or fiction? Front Immunol (2014) 0.78
P-glycoprotein expression by peripheral blood mononuclear cells from human immunodeficiency virus-infected patients is independent from response to highly active antiretroviral therapy. Clin Diagn Lab Immunol (2003) 0.77
HIV infection of monocytes-derived dendritic cells inhibits Vγ9Vδ2 T cells functions. PLoS One (2014) 0.77
Increased caspase activity primes human Lyme arthritis synovial γδ T cells for proliferation and death. Hum Immunol (2011) 0.77
Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS One (2015) 0.76
The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease. AIDS Res Hum Retroviruses (2013) 0.76
Interleukin-18 activates Vg9Vd2+ T cells from HIV+ Individuals: Recovering the Response to Phosphoantigen. Immunology (2017) 0.75
Vγ9Vδ2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count. PLoS One (2015) 0.75
Distortion of memory Vδ2 γδ T cells contributes to immune dysfunction in chronic HIV infection. Cell Mol Immunol (2014) 0.75
Potential Role of Vδ2(+) γδ T Cells in Regulation of Immune Activation in Primary HIV Infection. Front Immunol (2017) 0.75
Organisation and sequences at the 5' end of a cloned complete ovalbumin gene. Nature (1979) 9.30
The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A (1993) 4.97
Organization and sequence studies of the 17-piece chicken conalbumin gene. Nature (1979) 4.36
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science (1994) 3.90
Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA (1998) 3.71
Molecular cloning of extensive sequences of the in vitro synthesized chicken ovalbumin structural gene. Nucleic Acids Res (1977) 3.32
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Cloning of an almost full-length chicken conalbumin double-stranded cDNA. Nucleic Acids Res (1979) 2.39
Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29
Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol (1995) 2.12
Role of tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect Immun (2000) 2.09
Electron microscopy and restriction enzyme mapping reveal additional intervening sequences in the chicken ovalbumin split gene. Cell (1978) 2.08
Characterization of the structural gene and putative 5'-regulatory sequences for human proopiomelanocortin. Nature (1982) 2.04
[Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]. Pathol Biol (Paris) (1982) 1.90
A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods (2001) 1.72
Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol (1995) 1.70
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake. J Pathol (2007) 1.44
In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice. Infect Immun (1984) 1.44
Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide. Proc Natl Acad Sci U S A (1980) 1.44
Immunohistologic analysis of mycobacterial antigens by monoclonal antibodies in tuberculosis and mycobacteriosis. Hum Pathol (1989) 1.41
Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol (1997) 1.38
Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis (1999) 1.36
CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons. J Immunol (1995) 1.33
The chicken conalbumin gene: studies of the organization of cloned DNAs. Nucleic Acids Res (1979) 1.31
An overview of T-suppressor cell circuits. Annu Rev Immunol (1986) 1.30
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J Immunol (1997) 1.30
Hapten-specific T suppressor factor recognizes both hapten and I-J region products on haptenized spleen cells. Nature (1982) 1.28
p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene (1998) 1.27
Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J Immunol Methods (1997) 1.26
Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria. Infect Immun (1996) 1.25
Characterization of an IS-like element from Mycobacterium tuberculosis. J Gen Microbiol (1993) 1.23
Multiple initiation and polyadenylation sites for the chicken ovomucoid transcription unit. J Mol Biol (1982) 1.22
A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types. J Exp Med (1987) 1.21
Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol (1997) 1.21
Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage. Gene (2000) 1.20
3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human gammadelta T cells. J Biol Chem (1999) 1.20
Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol (1998) 1.18
Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production. Immunology (1984) 1.15
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse]. Rev Mal Respir (1985) 1.15
Influence of microbial infections on the progression of HIV disease. Trends Microbiol (1997) 1.14
The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol (1993) 1.10
Depression of contact sensitivity by enhancement of suppressor cell activity in Pseudomonas aeruginosa-injected mice. Infect Immun (1978) 1.08
Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol (1996) 1.07
Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay. Cytometry (2001) 1.06
Pro-apoptotic effect of the hepatitis B virus X gene. Biomed Pharmacother (1998) 1.06
Candida albicans polysaccharide extract (MPPS) and PPD stimulate the production of interleukin-1 and lymphocyte proliferation. Clin Exp Immunol (1984) 1.05
The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human gamma delta T cells. Infect Immun (1995) 1.04
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon. Arch Virol (2011) 1.04
Induction of "tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues. Proc Natl Acad Sci U S A (1996) 1.03
Diagnosis of tuberculosis: available technologies, limitations, and possibilities. J Clin Lab Anal (2003) 1.03
Human immunodeficiency virus infection and AIDS in a person with negative serology. J Infect Dis (1997) 1.03
Dissociation between interleukin-1 and interleukin-2 production in proliferative response to microbial antigens: restorative effect of exogenous interleukin-2. Infect Immun (1985) 1.02
Immunogenic cells in the regional lymph nodes after painting with the contact sensitizers picryl chloride and oxazolone: evidence for the presence of IgM antibody on their surface. Immunology (1983) 1.02
Auto-anti-idiotypic antibodies inhibit T-cell-mediated hypersensitivity in BCG-infected mice. Cell Immunol (1983) 1.02
gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. Immunology (2000) 1.02
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Hum Retroviruses (1999) 1.01
Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons. Apoptosis (2005) 1.01
[Quantitative determination method of nucleic acids by enzymatic amplification (PCR method) to saturation]. C R Acad Sci III (1992) 1.01
Innate T-cell immunity to nonpeptidic antigens. Immunol Today (1998) 1.00
[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse]. Rev Fr Mal Respir (1983) 1.00
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Hum Immunol (2001) 1.00
Generation and characterization of monoclonal antibodies to 28-, 35-, and 65-kilodalton proteins of Mycobacterium tuberculosis. Infect Immun (1988) 0.99
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. Tissue Antigens (2003) 0.99
Tissue transglutaminase: apoptosis versus autoimmunity. Immunol Today (1999) 0.99
Surface expressed heat-shock proteins by stressed or human immunodeficiency virus (HIV)-infected lymphoid cells represent the target for antibody-dependent cellular cytotoxicity. Immunology (1992) 0.98
Reduced immune activation and T cell apoptosis in human immunodeficiency virus type 2 compared with type 1: correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution. J Infect Dis (2000) 0.98
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. J Med Virol (2007) 0.98
Lipid modification of the Cu,Zn superoxide dismutase from Mycobacterium tuberculosis. Biochem J (2001) 0.97
Lack of 'tissue' transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLIpr/Ipr mice. Cell Death Differ (1997) 0.97
Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells. Cell Death Differ (2006) 0.97
Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons. Eur J Immunol (1999) 0.95
Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97. Infect Immun (2001) 0.95
Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis. Curr Mol Med (2001) 0.95
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability. J Infect Dis (2000) 0.94
Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis. Eur Respir J (2004) 0.94
Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. Virology (1996) 0.93
Human gamma delta T cells in tuberculosis. Res Immunol (1997) 0.93
The seroepidemiology of rubella in western Europe. Epidemiol Infect (2000) 0.93
gamma delta cells involved in contact sensitivity preferentially rearrange the Vgamma3 region and require interleukin-7. Eur J Immunol (1997) 0.93
Possible protective and pathogenic roles of gamma delta T lymphocytes in HIV-infections (Review). Int J Mol Med (1998) 0.93